The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
11 2019
Historique:
received: 27 03 2019
revised: 30 05 2019
accepted: 20 06 2019
pubmed: 30 9 2019
medline: 21 10 2020
entrez: 30 9 2019
Statut: ppublish

Résumé

In anti-glomerular basement membrane (anti-GBM) disease, IgG class autoantibodies induce rapidly progressive glomerulonephritis. Regrettably, many patients are diagnosed at a late stage when even intensive conventional treatment fails to restore renal function The endopeptidase IdeS (Immunoglobulin G degrading enzyme of Streptococcus pyogenes) (imliflidase) rapidly cleaves all human IgG subclasses into F(ab')

Identifiants

pubmed: 31563334
pii: S0085-2538(19)30769-0
doi: 10.1016/j.kint.2019.06.019
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Mac-1-like protein, Streptococcus 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1234-1238

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Inga Soveri (I)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: inga.soveri@medsci.uu.se.

Johan Mölne (J)

Department of Pathology and Genetics, Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Fredrik Uhlin (F)

Departments of Nephrology and Medical and Health Sciences, Linköping University, Linköping, Sweden; Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.

Thomas Nilsson (T)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Christian Kjellman (C)

Hansa Biopharma, Lund, Sweden.

Elisabeth Sonesson (E)

Hansa Biopharma, Lund, Sweden.

Mårten Segelmark (M)

Departments of Nephrology and Medical and Health Sciences, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH